Atlas Venture Associates Opportunity I, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/01/16

Trade details

Type: Insider sale
Amount: $1,362.42
Shares · price: 1,566 sh · $0.87 a share
Held after: 2,021,836 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Associates Opportunity I10% Owner
Trade date: 24/01/11
Filed: 24/01/16
Days to filing: 5 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/12~24/02/10

Atlas Venture Associates Opportunity I's recent trades

Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$5.3M
126,066 sh
$5.3M
Filed 24/03/13
Traded 24/03/12
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$4.6M
108,404 sh
$4.6M
Filed 24/03/13
Traded 24/03/13
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.6M
37,180 sh
$1.6M
Filed 24/03/13
Traded 24/03/11
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.1M
26,452 sh
$1.1M
Filed 24/03/13
Traded 24/03/12
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$961K
22,779 sh
$961K
Filed 24/03/13
Traded 24/03/13

Atlas Venture Associates Opportunity I, 10% Owner — sold $1,362 of Xilio Therapeutics XLO · 0.1% of holdings | Whalegun